Since PTL has been reported to have significant anti-inflammatory effects in vitro and its mechanism includes specific inhibition of the NF-kB pathway 27, the anti-inflammatory and anti-bacterial effects in vivo, especially in IBD, have rarely been described. The gene discussed is NFKB1; the disease is inflammatory bowel disease.